Aspen Neuroscience, which is developing stem cell therapies for Parkinson's disease, sold 9.37 million shares, slightly below ...

While praising the breadth of its pipeline, AstraZeneca has launched a three-year cost-cutting programme that will aim to ...

Belén Garijo, who took over the reins of the French pharma group in April, said this morning that Sanofi's "whole ...

The US federal government has awarded $99 million in funding for a one-shot vaccine against the Bundibugyo virus (BDBV), the ...

Flagship Pioneering has formed a new AI-focused biotech company, called Etcelera, by combining the platforms of three firms ...

The Novartis Pavillon in Park South of the Novartis Campus in Basel, Switzerland. Novartis's third-quarter results included a ...

Dren Bio has closed a sizeable private financing round, raising $350 million to fund pivotal trials of its potentially ...

Switzerland's Ferring Pharma has reached an agreement to buy US women's health startup Gameto for up to $1.38 billion, ...

Sofe-m was acquired by Lilly as part of its 2023 takeover of French biotech Mablink Bioscience and its PSARLink ADC ...

While Anthropic has not disclosed the number of shares to be released, their price range, or a date for the listing, ...

Among the highlights of UK Chancellor John Healey's first Budget was more than £1 billion in investment by Convatec, Vertex ...

Eli Lilly has added another arrow to the quiver of its new diabetes and weight-loss therapy retatrutide, comprehensively ...